Selected stock price target news of the day - February 4th, 2025

By: Matthew Otto

Palantir Reports Q4 EPS and Revenue Beat, Projects 2025 Growth Above Estimates

Palantir Technologies delivered its financial results, reporting fourth-quarter revenue of $827.5 million, up 36% year-over-year, exceeding the consensus estimate of $778.17 million. Earnings per share (EPS) for the quarter were $0.14, outperforming analyst projections of $0.11.

U.S. commercial revenue surged 64% year-over-year and 20% quarter-over-quarter to $214 million, while U.S. government revenue increased 45% year-over-year to $343 million. Palantir secured 129 deals worth at least $1 million, including 32 deals valued at $10 million or more. Operating cash flow stood at $460 million, representing a 56% margin, while adjusted free cash flow reached $517 million.

Looking forward, Palantir provided optimistic guidance for 2025, forecasting Q1 revenue between $858 million and $862 million, surpassing the consensus estimate of $799.4 million. For the full year, Palantir projects revenue between $3.741 billion and $3.757 billion, above the consensus of $3.53 billion.

Analysts Adjust Ratings and Price Targets Following Q4 and 2025 Guidance

Baird analyst William Power maintained a Neutral rating while raising the price target from $70 to $100.
Northland Capital Markets analyst Michael Latimore maintained a Market Perform rating yet increased the price target from $38 to $80.
Mizuho analyst Matthew Broome reiterated an Underperform rating but raised the price target from $44 to $80.
Morgan Stanley analyst Sanjit Singh upgraded from Underweight to Equal-Weight and the price target from $60 to $95.
BofA Securities analyst Mariana Perez Mora kept a Buy rating while increasing the price target from $90 to $125.
Jefferies analyst Brent Thill maintained an Underperform rating, although lifted the price target from $28 to $60.

Which Analyst has the best track record to show on PLTR?

Analyst Brian Gesuale (RAYMOND JAMES) currently has the highest performing score on PLTR with 6/6 (100%) price target fulfillment ratio. His price targets carry an average of $3.41 (12.82%) potential upside. Palantir Technologies stock price reaches these price targets on average within 153 days.

Fabrinet Exceeds Q2 Expectations, Provides Optimistic Q3 Guidance Above Consensus

Fabrinet reported financial results, posting GAAP revenue of $833.6 million, a 16.9% increase from $712.7 million in the same period last year. It surpassed the consensus estimate of $813.86 million. GAAP net income rose to $86.6 million, up 25.3% from $69.1 million in the prior-year quarter. GAAP net income per diluted share was $2.38, compared to $1.89 previously. On a non-GAAP basis, net income increased 25% year-over-year to $95.1 million, with non-GAAP earnings per diluted share of $2.61, beating analyst expectations of $2.50 by $0.11.

Fabrinet’s telecom business performed due to increased demand for datacenter interconnect products and early gains from recent system wins. Despite moderated near-term demand in the datacom segment, Fabrinet expects accelerated growth as next-generation products ramp up production. Fabrinet also expanded its share repurchase program by an additional $100 million, bringing the total authorization to $534.3 million.

Looking ahead, Fabrinet provided upbeat guidance for the third fiscal quarter, projecting revenue between $850 million and $870 million, above the $825 million consensus. GAAP net income per diluted share is expected to be between $2.32 and $2.40, while non-GAAP net income per diluted share is forecasted between $2.55 and $2.63, in line with the consensus estimate of $2.55.

Analysts Adjust Price Targets Following Q2 Results

Barclays analyst George Wang maintained an Equal-Weight rating but lowered the price target from $292 to $245.
Needham analyst Ryan Koontz reiterated a Buy rating and price target at $280.
Rosenblatt analyst Mike Genovese maintained a Buy rating and raised the price target from $280 to $285.

Which Analyst has the best track record to show on FN?

Analyst Samik Chatterjee (JPMORGAN) currently has the highest performing score on FN with 14/15 (93.33%) price target fulfillment ratio. His price targets carry an average of $17 (6.34%) potential upside. Fabrinet stock price reaches these price targets on average within 76 days.

IDEXX Reports Q4 Results, Exceeds Earnings Estimates, and Provides 2025 Guidance

IDEXX Laboratories reported fourth-quarter results for 2024, with revenue reaching $954.28 million, surpassing the consensus estimate of $933.38 million. IDEXX achieved a 6% increase in revenue, driven by performance in its Companion Animal Group (CAG). CAG Diagnostics recurring revenue grew by 6% reported and 7% organically, supported by a 9% year-over-year expansion in IDEXX’s global premium instrument installed base, customer retention, and new business.

Fourth-quarter earnings per diluted share (EPS) were $2.62, exceeding the analyst estimate of $2.39 by $0.23, reflecting a 13% increase on a reported basis and 10% on a comparable basis. This growth was fueled by operating results, which included a 20 basis point improvement in operating margin, partially offset by currency impacts and tax benefits related to share-based compensation.

Looking ahead, IDEXX has provided initial guidance for fiscal year 2025, projecting revenue between $4.05 billion and $4.17 billion. This reflects a 4% to 7% growth on a reported basis and 6% to 9% organically. IDEXX’s forecast for 2025 EPS is $11.74 to $12.24, slightly below the consensus of $11.84. The expected EPS growth represents a 10% to 15% increase on a reported basis and 8% to 12% on a comparable basis.

Analysts Adjust Price Targets Following Q4 Performance

Barclays analyst Balaji Prasad maintained an Overweight rating and raised the price target from $481 to $520.
BofA Securities analyst Michael Ryskin kept a Neutral rating, while increasing the price target from $475 to $535.

Which Analyst has the best track record to show on IDXX?

Analyst David Westenberg (PIPER SANDLER) currently has the highest performing score on IDXX with 7/8 (87.5%) price target fulfillment ratio. His price targets carry an average of $15.09 (3.59%) potential upside. IDEXX Laboratories stock price reaches these price targets on average within 58 days.